SCHEMBL18934348

SCHEMBL18934348

c1ccc(-n2c3cc4[nH]c5ccccc5c4cc3n3c4ccccc4nc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.41
AHR P35869 1/20 0.41
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
PDE7A Q13946 2/20 0.36
PDE7B Q9NP56 2/20 0.36
KDM4E B2RXH2 6/20 0.35
HSD17B10 Q99714 3/20 0.35
MAPT P10636 3/20 0.35
LMNA P02545 2/20 0.35
TP53 P04637 2/20 0.35
POLB P06746 1/20 0.35
ALDH1A1 P00352 5/20 0.35
HPGD P15428 4/20 0.35
GPR3 P46089 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KIF11 P52732 2/20 0.34
GAA P10253 2/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20616762 1.00 TOP2A (0.41) TOP2AAHRMAPK1HTTPDE7A
SCHEMBL18934858 0.86 AHR (0.41) TOP2AAHRPDE7APDE7BKDM4E
SCHEMBL18934354 0.86 AHR (0.41) TOP2AAHRPDE7APDE7BKDM4E
SCHEMBL18698129 0.86 HPGD (0.37) TOP2AAHRMAPK1HTTPDE7A
SCHEMBL18687112 0.86 HPGD (0.37) TOP2AAHRMAPK1HTTPDE7A
SCHEMBL20448094 0.86 ALDH1A1 (0.37) TOP2AAHRMAPK1HTTPDE7A
SCHEMBL23219318 0.82 TOP2A (0.40) TOP2AAHRKDM4EHSD17B10MAPT
SCHEMBL12800982 0.82 TOP2A (0.40) TOP2AAHRKDM4EHSD17B10MAPT
SCHEMBL30876355 0.82 TOP2A (0.40) TOP2AAHRKDM4EHSD17B10MAPT
SCHEMBL18934334 0.81 MAPK1 (0.50) MAPK1HTTKDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2021-11-16 US disclosed
US-20190002469-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-01-03 US disclosed
WO-2017093958-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2017-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174258-B2 Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes KCNH2, KCNH3, KCNJ2 TOP2A 2653/4885AHR 2264/4885MAPK1 2877/4885
US-20190002469-A1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES KCNH2, KCNH3, KCNJ2 TOP2A 2653/4885AHR 2264/4885MAPK1 2877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.